Top 10 Heal Care Stocks To Buy Right Now


Getty Images

Investors might be giving up on the so-called reflation trade too soon, according to Deutsche Bank.

Top 10 Heal Care Stocks To Buy Right Now: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.


    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.


    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:


    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS). Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

Top 10 Heal Care Stocks To Buy Right Now: CytRx Corporation(CYTR)


Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.


    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Heal Care Stocks To Buy Right Now: AdvanSix Inc. (ASIX)


Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Vodafone Group (VOD) , Schlumberger (SLB) , Encana (ECA) , Arconic (ARNC) and AdvanSix (ASIX) .

    Cramer was bearish on U.S. Silica Holdings (SLCA) .

Top 10 Heal Care Stocks To Buy Right Now: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Gary Jakacky]

    Only one company convincingly jumped thru all the hoops: C.H. Robinson Worldwide, Inc. (CHRW).


    If only one of the companies in IYT appear to be undervalued, it might give you pause about how brightly the ETF will shine in the very near future.

  • [By Lisa Levin]

    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) were down 4 percent to $71.69. UBS downgraded C.H. Robinson Worldwide from Neutral to Sell.

  • [By Chad Tracy]

    As it's known today, C.H. Robinson (Nasdaq: CHRW) has again changed with the times.

    Unlike transportation industry titans FedEx (NYSE: FDX) or UPS (NYSE: UPS), C.H. Robinson does not own a fleet of trucks that transport goods. Instead, it specializes in logistics. Other companies hire C.H. Robinson to make their transportation services more efficient.

Top 10 Heal Care Stocks To Buy Right Now: Exxon Mobil Corporation(XOM)


Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    As one of the biggest energy stocks on the planet, its always worth watching Exxon Mobil Corporation (XOM). After all, as goes XOM, so goes the rest of the industry. But this quarter, the reason to watch Exxon is because of the something it doesnt do that the rest of the industry does. Namely, write down the value of assets.

  • [By Money Morning News Team]

    Big oil stocksare some of the most recognizable companies in energy, but they won’t bring you the big-time profits you’re looking for. Instead, we’ve got “small” oil stocks that are ready to soar by double digits in 2017 while the bloated oil giants like Exxon Mobil Corp. (NYSE: XOM) tread water.

  • [By Wayne Duggan]

    Disappointment with the pace of the global oil market recovery once again has Exxon Mobil Corporation (NYSE: XOM) shares trading near the critical $80 support level. A breakdown below $80 support could be bad news for Exxon bulls. Here's why.

  • [By Jack Delaney]

    Some of the most well-known dividend aristocrats include:

    Exxon Mobil Corp. (NYSE: XOM) pays a dividend of $0.77, which is a yield of 3.75%. Aflac Inc. (NYSE: AFL) pays a dividend of $0.43, which is a yield of 2.32%. AT&T Inc. (NYSE: T) pays a dividend of $0.49, which is a yield of 5.12%. T-Rowe Price Group Inc. (Nasdaq: TROW) pays a dividend of $0.57, which is a yield of 3.27%. Clorox Co. (NYSE: CLX) pays a dividend of $0.84, which is a yield of 2.50%.


    If you just kept the dividends, your investment would be worth $11,147. That’s a difference of only $25. So it may not seem like a big deal at first glance.

  • [By Paul Ausick]

    Exxon Mobil Corp. (NYSE: XOM) traded down 1.59% at $81.21. The stock’s 52-week range is $80.76 to $95.55. Volume was about equal to the daily average of around 12 million shares. The company had no news, but the large increase in crude inventories really pounded both Exxon and Chevron this afternoon.

Top 10 Heal Care Stocks To Buy Right Now: Insulet Corporation(PODD)


Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Brian Feroldi]

    Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation peaking in 2014 before falling below the more steady performance of diabetes or insulin stocks like large cap Novo Nordisk A/S (NYSE: NVO) and small cap Insulet Corporation (NASDAQ: PODD):

Top 10 Heal Care Stocks To Buy Right Now: Farmer Brothers Company(FARM)

Advisors’ Opinion:

  • [By Matt Hogan]

    Finbox.io fair value data (as of January 4) shows that there are only five US manufacturing stocks that have 25% or more margin of safety: Vera Bradley, Inc. (NASDAQ: VRA), Cooper Tire & Rubber Co (NYSE: CTB), Farmer Brothers Co. (NASDAQ: FARM), Allergan plc Ordinary Shares (NYSE: AGN) and Motorcar Parts of America, Inc. (NASDAQ: MPAA).

Top 10 Heal Care Stocks To Buy Right Now: Sotheby's(BID)


Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of auction house Sotheby’s (NYSE:BID) jumped as much as 14.7% in trading Monday after the company released fourth-quarter results. And shares kept steaming, trading 13.6% higher as of 12:30 p.m. EST.

  • [By Marshall Hargrave]

    Now Loeb's looking to put that capital to work in other markets, with the art market being a perfect candidate. Loeb and his Third Point hedge fund have started their latest activist campaign with leading auction house Sotheby's (NYSE: BID). Loeb joins fellow activist investor Marcato Capital in the stock.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Carrizo Oil and Gas Inc. (NASDAQ: CRZO), Medifast Inc. (NYSE: MED), Medley Capital Corp. (NYSE: MCC), Occidental Petroleum Corp. (NYSE: OXY) and Sothebys (NYSE: BID).

  • [By Travis Hoium]

    Shares of auction house Sotheby’s (NYSE:BID) jumped 13.6% in February, according to data provided by S&P Global Market Intelligence, after a fourth-quarter earnings report wowed investors. And given the company’s momentum, 2017 could be a great year for the company.

Top 10 Heal Care Stocks To Buy Right Now: Gogo Inc.(GOGO)


Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small capin-flight WiFi stockGogo Inc (NASDAQ: GOGO) is scheduled for before the market opens onMonday (February 27th). Last summer, American Airlines did a deal with rival ViaSat, Inc (NASDAQ: VSAT) to provide Internet access on about 100 new Boeing jets. To add to the turbulence, Moody’s Investors Service assigned a B3 Corporate Family Rating, a B3-PD Probability of Default Rating and a SGL-2 Speculative Grade Liquidity Rating to Gogo Inc plus assigned a B2 (LGD3) rating to the Company’s $500 senior secured note offering (after a planned sale of $525 millionin junk bonds fell through). The Ratings Action noted:

  • [By Lisa Levin]

    Shares of Gogo Inc (NASDAQ: GOGO) got a boost, shooting up 19 percent to $10.85 after the company reported a narrower-than-expected quarterly loss.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00


    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Lee Jackson]

    Gogo Inc. (NASDAQ: GOGO) had a director purchasing a total of 300,000 shares at $9.69 per share. The total for the purchase was posted at $3 million.Gogo provides communications services to the commercial and business aviation markets in the United States and internationally. Itsstock was trading on Friday at $8.85.

  • [By Steve Symington]

    Shares of Gogo Inc. (NASDAQ:GOGO) were up 18.3% as of 1:30 p.m. EST Monday after the in-flight connectivity specialist announced stronger-than-expected fourth-quarter 2016 results.

  • [By Dan Caplinger]

    Monday started the new week on a positive note, as the stock market once again recovered from early declines to post advances. The Dow Jones Industrials extended its string of record closes to 12 consecutive days in the wake of favorable comments from Warren Buffett about the valuation of the market. Moves within the Trump administration to transfer spending to the Defense Department also bolstered the overall market mood. In addition, good news from certain companies helped to sustain positive sentiment overall, and Advanced Micro Devices (NASDAQ:AMD), Windstream Holdings (NASDAQ:WIN), and Gogo (NASDAQ:GOGO) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Heal Care Stocks To Buy Right Now: Novo Nordisk A/S(NVO)


Advisors’ Opinion:

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Paul Ausick]

    Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Friday to post a new 52-week low of $32.35 after closing at $32.84 on Thursday. The stock’s 52-week high is $59.00. Volume of about 3.4 million was close to the daily average of around 3.9 million shares. The drug maker had no specific news.

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

Leave a Reply

Your email address will not be published. Required fields are marked *